GlassScriptPhysician profile
Luis Manuel Muniz
NPI 1699961375
$1,620.31
in general payments reported to CMS, 2019-2025
15 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $96.00 · 2021: $273 · 2022: $153 · 2023: $278 · 2024: $128 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $452.76 | 2019-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Tolmar Pharmaceuticals, INC. | $153.93 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $144.94 | 2021-2025 | Tlando |
| E.R. Squibb & Sons, L.L.C. | $124.97 | 2023 | Opdivo |
| Olympus Latin America, INC. | $108.00 | 2019 | |
| Neotract INC. | $105.00 | 2019 | |
| Teleflex LLC | $102.60 | 2021 | |
| Merck Sharp & Dohme LLC | $90.00 | 2024 | Keytruda |
| Medtronic, INC. | $80.00 | 2019 | |
| Tolmar, INC. | $78.00 | 2023 | |
| Amgen INC. | $74.15 | 2019 | |
| Abbvie INC. | $55.74 | 2019 | |
| Pharmaand Gmbh | $22.20 | 2024 | Rubraca |
| Pbg Puerto Rico LLC | $14.68 | 2021 | |
| Pfizer INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Muniz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.